Enveric Biosciences, Inc. Cash And Cash Equivalents At Carrying Value

• Enveric Biosciences, Inc. showed a decrease of -68.5% in Cash And Cash Equivalents At Carrying Value from 2018 to 2019.
• This data is from Enveric Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2020.
• XBRL data for this metric is available from 2009 to 2019 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2010: $4.2 thousand | Q1 2011: $2.2 thousand | Q2 2011: $3.8 thousand | Q3 2011: $20.2 thousand | Q1 2012: $6.1 thousand | Q2 2012: $2.2 thousand | Q3 2012: $2.1 thousand | Q1 2013: $1.2 thousand | Q2 2013: $2.4 thousand | Q3 2013: $684.00 | Q4 2013: $249.00 | Q1 2014: $22.5 thousand | Q2 2014: $7.8 thousand | Q3 2014: $9.1 thousand | Q4 2014: $5.1 thousand | Q1 2015: $825.6 thousand | Q3 2015: $5.07 million | Q1 2016: $505.2 thousand | Q2 2016: $3.60 million | Q3 2016: $2.91 million | Q1 2017: $1.81 million | Q2 2017: $1.04 million | Q3 2017: $844.1 thousand | Q1 2018: $1.76 million | Q2 2018: $915.1 thousand | Q3 2018: $2.06 million | Q1 2019: $1.72 million | Q2 2019: $1.60 million | Q3 2019: $499.7 thousand | Q4 2019: $431.4 thousand | Q1 2020: $1.27 million | Q2 2020: $2.09 million | Q3 2020: $2.84 million.
• Over the full 11 years of available data (2009 to 2019), Enveric Biosciences, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 23,973.7%.
• Historical annual values: Fiscal year 2019: $431.4 thousand | Fiscal year 2018: $1.37 million | Fiscal year 2017: $4.88 million | Fiscal year 2016: $1.38 million | Fiscal year 2015: $1.88 million | Fiscal year 2014: $5.1 thousand | Fiscal year 2013: $249.00 | Fiscal year 2012: $1.4 thousand | Fiscal year 2011: $18.2 thousand | Fiscal year 2010: $1.1 thousand | Fiscal year 2009: $1.8 thousand.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026